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Journal of Prosthodontic Research 57 (2013) 1–2Because the deficiency of alveolar bone volume is a critical
problem in various interventions for missing teeth, many
attempts have been made to augment alveolar bone as a
preprosthetic surgical treatment [1]. Basically, four principles
have been used in combination or alone to augment bone
volume:
1. Osteoconduction; uses grafting materials to serve as
scaffolds for new bone growth.
2. Guided bone regeneration (GBR); allows selective bone
tissue growth into a space protected by barrier membranes.
3. Bone splitting or distraction osteogenesis; enables new bone
formation by surgically induced bone fracture.
4. Osteoinduction; uses appropriate growth factors that modu-
late cells to promote new bone formation.
Among these principles, osteoconduction and GBR are
frequently used and well documented for the treatment of
localized bone defects in the jaws, probably because of
simplicity of use while allowing the placement of dental
implants in areas with bony defects and/or insufficient bone
volume. With regard to osteoconduction, the choice of grafting
materials is the key to achieving a predictable clinical outcome.
In general, autogenous bone is thought to be the gold standard,
and it has many advantages over the alternatives. However, it
needs to be harvested from a donor site, which means more
invasive surgery and higher morbidity. Therefore several
osteoconductive synthetic biomaterials (alloplasts) have been
developed and frequently used as graft materials.
GBR uses barrier membranes to protect the bone
augmentation site from nonosteogenic tissue in growth.
However, several human clinical trials of GBR have proved
that membrane-protected bone regeneration takes considerable
time to reach the desired clinical outcome. For clinical
applications, a prolonged healing period of 6 or more months is
a problem. The big issue of GBR might be the barrier
membrane itself. The periosteum has an osteogenetic function,
and it is responsible for forming new bone as a result of injury.
AVolkmann’s canal is one that allows the transmission of blood
vessels (or capillaries) from the periosteum into the bone. The1883-1958    # 2013 Published by Elsevier Ireland on behalf of Japan Prosthodonti
http://dx.doi.org/10.1016/j.jpor.2013.01.003barrier membrane is useful for protecting a bone-forming
space; from a different point of view, however, the barrier
membrane actually separates bone from the periosteum to
obstruct bone maturation.
In this issue, Rakhmatia et al. reviewed current barrier
membranes [2], focusing especially on titanium mesh applica-
tions for GBR. The review reports that titanium mesh maintains
space more predictably, even in cases with large bone cavities,
and resists collapsing better than other membranes. In my
opinion, the advantage of titanium mesh is not only its
mechanical properties, but also its high porosity, which allows
appropriate passages to be provided between bone and the
periosteum.
Nevertheless, no practical approach is currently available to
shorten the healing period of GBR. One promising method to
accelerate bone regeneration is the use of cytokines to stimulate
bone cell proliferation and differentiation.
In this respect, several studies have been published in recent
years with regard to osteoinduction. Akagawa et al. reported in
the Journal of Prosthodontic Research (JPR) [3] that the use of
locally applied slow-degradation-type basic fibroblast growth
factor (FGF) – a gelatin hydrogel complex – may accelerate
early-stage bone regeneration around fenestrated implants. In
general, basic FGF (bFGF; the same as FGF-2) is a major
cytokine found in various body tissues and is characterized by
its capacity to stimulate the proliferation and differentiation of a
wide variety of mesodermal and neuroectodermal cells. From
the results of animal studies, not only have Bone Morphogenic
Proteins (BMPs) been shown to induce tremendous bone
growth in many animal and some human clinical studies, but
also bFGF might be a strong candidate for enhancing bone
formation in the treatment site.
In the future, the use of regenerative medicine, especially stem
cell technology in dentistry, could be the most noteworthy
strategy of the regeneration of missing oral tissues. In vol. 56,
issues 3 and 4, of JPR, Egusa et al. have published a series of
comprehensive review papers that covered a wide range of topics
about stem cell technology in dentistry [4,5]. In these reviews, the
authors clearly stated that in the field of prosthodontics,
especially in the clinic, material-based reconstruction withoutc Society. Open access under CC BY-NC-ND license.
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however, emerging stem cell technologies and the requirements
of alveolar ridge augmentation associated with implant dentistry
have expanded the clinical concept to include stem-cell-based
regeneration.
But we must admit that there may still be an ever-present
danger of postoperative resorption of augmented bone. To our
regret, this unfavorable phenomenon is not preventable at
present. We should soon achieve a breakthrough to make
outcomes of preprosthetic surgery more predictable and more
sustainable.
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